BIS

ProShares UltraShort Nasdaq Biotechnology

BIS Fund Description

The ProShares UltraShort NASDAQ Biotech provides -2x exposure to a market-cap weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

BIS Factset Analytics Insight

BIS provides daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index. It charges 95 bps for holding swaps on the index and the iShares Biotech ETF (IBB), which reaches beyond pure biotechnology into pharmaceuticals, and tilts smaller than our benchmark, in addition to excluding NYSE-listed firms. BIS has increased assets to a reasonable level, which has helped liquidity for investors, though spreads are still sizeable. Unfortunately, BIS is the only fund in the inverse biotech space. Note: BIS is a tactical tool. Due to daily compounding, it's unlikely to achieve its stated exposure and returns for longer than a one-day period, but with its high expense ratio, most investors probably won't want to hang onto it for long anyway.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
12:32:4023.30432
09:46:1423.2892
09:46:1423.288
09:45:2523.2697
------
------
------
------
------
------
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

BIS Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a 5 out of 5.

BIS Summary Data

ProShares
04/08/10
Open-Ended Fund
0.95%
$43.1M
0.23%

BIS Portfolio Data

0.00%
12/26/17

BIS Index Data

Market Cap
NASDAQ - Listed
N/A

BIS Fund Structure

Yes
No
No Policy
N/A
N/A
Medium
-2
Daily

BIS Tax Exposures

20% / 39.6%
--
No

BIS Tradability

54,434
$1.19M
47,135
$1.09M
0.23%
0.00%
0.23% / -0.36%
None
50,000
0.94
0.02%
1,151
$23.55
5